Mon, June 26, 2023
Fri, June 23, 2023
Thu, June 22, 2023
Wed, June 21, 2023
Tue, June 20, 2023
Mon, June 19, 2023
Fri, June 16, 2023
Thu, June 15, 2023

Ed Arce Reiterated (AKBA) at Hold and Held Target at $2 on, Jun 21st, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -hold-and-held-target-at-2-on-jun-21st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ed Arce of HC Wainwright & Co., Reiterated "Akebia Therapeutics, Inc." (AKBA) at Hold and Held Target at $2 on, Jun 21st, 2023.

Ed has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $4 on, Wednesday, May 31st, 2023

Publication Contributing Sources